Citations (5)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Giuseppe Castaldo, Manuela Scorza, Ausilia Elce, Sonia Giordano, Renato Liguori & Germano Guerra. (2013) Omics in laboratory medicine. The Journal of Maternal-Fetal & Neonatal Medicine 26:sup2, pages 13-16.
Read now
Read now
Ya-Zhen Qin, Hong-Hu Zhu, Yan-Rong Liu, Ya-Zhe Wang, Hong-Xia Shi, Yue-Yun Lai, Lan-Ping Xu, Dai-Hong Liu, Qian Jiang, Ling-Di Li, Bin Jiang, Kai-Yan Liu & Xiao-Jun Huang. (2013) PRAME and WT1 transcripts constitute a good molecular marker combination for monitoring minimal residual disease in myelodysplastic syndromes. Leukemia & Lymphoma 54:7, pages 1442-1449.
Read now
Read now
Articles from other publishers (3)
R.M. Koldej & D.S. Ritchie. (2020) High multiplex analysis of the immune microenvironment in bone marrow trephine samples using GeoMX™ digital spatial profiling. Immuno-Oncology Technology 5, pages 1-9.
Crossref
Crossref
Johannes Kuehle, Soeren Turan, Tobias Cantz, Dirk Hoffmann, Julia D Suerth, Tobias Maetzig, Daniela Zychlinski, Christoph Klein, Doris Steinemann, Christopher Baum, Juergen Bode & Axel Schambach. (2014) Modified Lentiviral LTRs Allow Flp Recombinase–mediated Cassette Exchange and In Vivo Tracing of “Factor-free” Induced Pluripotent Stem Cells. Molecular Therapy 22:5, pages 919-928.
Crossref
Crossref
Christopher S. Hourigan & Judith E. Karp. (2013) Minimal residual disease in acute myeloid leukaemia. Nature Reviews Clinical Oncology 10:8, pages 460-471.
Crossref
Crossref